Save your place

Sign in to WhoBought

Please try again later.

Stoke Therapeutics, Inc. (STOK) institutional ownership

Latest close $28.81 Jul 21, 2026
Market cap$705M 52-week range SectorHealthcare
Funds holding · Q1 2026
194
reported STOK position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
116 buyers · 78 sellers

Stoke Therapeutics, Inc. (STOK) price and institutional activity

Dates

Q1 2026

$0 bought by 116 investors
Wellington Management Group LLPT. Rowe Price Associates +114 more
$0 sold by 78 investors
Point72 Asset Management, L.P.Lynx1 Capital Management LP +76 more
Bought Sold Totals per quarter; hover a bar for the names.

Stoke Therapeutics, Inc. (STOK) institutional activity · 194

Investor Type Est. change Change Δ Own Date
Wellington Management Group LLP · Added
Change +2.4M Δ Own +320.7% Date Q1 2026
Wellington Management Group LLP Added· Q1 2026 +2.4M +320.7% Q1 2026
T. Rowe Price Associates · Added
Change +1.6M Date Q1 2026
T. Rowe Price Associates Added· Q1 2026 +1.6M Q1 2026
Point72 Asset Management, L.P. · Exited
Change −1.2M Δ Own −100.0% Date Q1 2026
Point72 Asset Management, L.P. Exited· Q1 2026 −1.2M −100.0% Q1 2026
Troluce Capital Advisors LLC · New
Change +653K Date Q1 2026
Troluce Capital Advisors LLC New· Q1 2026 +653K Q1 2026
Lynx1 Capital Management LP · Reduced
Change −641K Date Q1 2026
Lynx1 Capital Management LP Reduced· Q1 2026 −641K Q1 2026
Millennium Management LLC · New
Change +472K Date Q1 2026
Millennium Management LLC New· Q1 2026 +472K Q1 2026
Bank of America Corp · Added
Change +337K Date Q1 2026
Bank of America Corp Added· Q1 2026 +337K Q1 2026
Baillie Gifford & Co · Added
Change +328K Date Q1 2026
Baillie Gifford & Co Added· Q1 2026 +328K Q1 2026
Assenagon Asset Management S.A. · Reduced
Change −321K Date Q1 2026
Assenagon Asset Management S.A. Reduced· Q1 2026 −321K Q1 2026
Artisan Partners Limited Partnership · New
Change +315K Date Q1 2026
Artisan Partners Limited Partnership New· Q1 2026 +315K Q1 2026
Goldman Sachs Group Inc · Reduced
Change −312K Date Q1 2026
Goldman Sachs Group Inc Reduced· Q1 2026 −312K Q1 2026
Bvf Inc · Added
Change +282K Date Q1 2026
Bvf Inc Added· Q1 2026 +282K Q1 2026
Siren, L.L.C. · Reduced
Change −252K Date Q1 2026
Siren, L.L.C. Reduced· Q1 2026 −252K Q1 2026
T. Rowe Price Investment Management, Inc. · New
Change +251K Date Q1 2026
T. Rowe Price Investment Management, Inc. New· Q1 2026 +251K Q1 2026
State Street · Reduced
Change −222K Date Q1 2026
State Street Reduced· Q1 2026 −222K Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 194

Famous investor activity in Stoke Therapeutics, Inc. (STOK)

Stoke Therapeutics, Inc. (STOK) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Harrison Seth Loring · Director 16 operations 0
Owned 18K Trade date Jul 16, 2026 Filed date Jul 17, 2026
Harrison Seth Loring Director 16 operations 0 18K Jul 16, 2026 Jul 17, 2026
McCauley Thomas · Officer Grant (A) 225K
Owned 225K Trade date Jul 15, 2026 Filed date Jul 17, 2026
McCauley Thomas Officer Grant (A) 225K 225K Jul 15, 2026 Jul 17, 2026
Ticho Barry · Officer 2 operations −$236K
Price $32.62–$33.27 Qty −7K Owned 28K ΔOwn −20.8% Trade date Jul 1, 2026 Filed date Jul 6, 2026
Ticho Barry Officer 2 operations $32.62–$33.27 −7K −$236K 28K −20.8% Jul 1, 2026 Jul 6, 2026
Allan Jonathan · Officer Sell −$44K
Price $29.95 Qty −1K Owned 18K Trade date Jun 16, 2026 Filed date Jun 18, 2026
Allan Jonathan Officer Sell $29.95 −1K −$44K 18K Jun 16, 2026 Jun 18, 2026
Tzianabos Arthur · Director Grant (A) 18K
Owned 18K Trade date Jun 3, 2026 Filed date Jun 5, 2026
Tzianabos Arthur Director Grant (A) 18K 18K Jun 3, 2026 Jun 5, 2026
Smith Julie · Director Grant (A) 18K
Owned 18K Trade date Jun 3, 2026 Filed date Jun 5, 2026
Smith Julie Director Grant (A) 18K 18K Jun 3, 2026 Jun 5, 2026
Levin Arthur A. · Director Grant (A) 18K
Owned 18K Trade date Jun 3, 2026 Filed date Jun 5, 2026
Levin Arthur A. Director Grant (A) 18K 18K Jun 3, 2026 Jun 5, 2026
Krainer Adrian R. · Director Grant (A) 18K
Owned 18K Trade date Jun 3, 2026 Filed date Jun 5, 2026
Krainer Adrian R. Director Grant (A) 18K 18K Jun 3, 2026 Jun 5, 2026
Kaye Edward M. Md · Director Grant (A) 18K
Owned 18K Trade date Jun 3, 2026 Filed date Jun 5, 2026
Kaye Edward M. Md Director Grant (A) 18K 18K Jun 3, 2026 Jun 5, 2026
Harrison Seth Loring · Director Grant (A) 18K
Owned 18K Trade date Jun 3, 2026 Filed date Jun 5, 2026
Harrison Seth Loring Director Grant (A) 18K 18K Jun 3, 2026 Jun 5, 2026
Burstein Jennifer · Director Grant (A) 18K
Owned 18K Trade date Jun 3, 2026 Filed date Jun 5, 2026
Burstein Jennifer Director Grant (A) 18K 18K Jun 3, 2026 Jun 5, 2026
Ticho Barry · Officer Sell −$55K
Price $30.58 Qty −2K Owned 35K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Ticho Barry Officer Sell $30.58 −2K −$55K 35K Jun 1, 2026 Jun 3, 2026
Ticho Barry · Officer Sell −$74K
Price $32.79 Qty −2K Owned 37K Trade date May 1, 2026 Filed date May 5, 2026
Ticho Barry Officer Sell $32.79 −2K −$74K 37K May 1, 2026 May 5, 2026
Kahn Clare · Director Grant (A) 31K
Owned 31K Trade date Apr 3, 2026 Filed date Apr 7, 2026
Kahn Clare Director Grant (A) 31K 31K Apr 3, 2026 Apr 7, 2026
Ticho Barry · Officer Sell −$60K
Price $32.66 Qty −2K Owned 39K Trade date Apr 1, 2026 Filed date Apr 3, 2026
Ticho Barry Officer Sell $32.66 −2K −$60K 39K Apr 1, 2026 Apr 3, 2026
15 of 94
15 of 94 Sign in to continue to older insider transactions.

Stoke Therapeutics, Inc. (STOK) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Skorpios Trust 6.9M
% of shares outstanding 14.9% Filing date Apr 18, 2024
Skorpios Trust 6.9M 14.9% Apr 18, 2024
BlackRock Inc. 5.4M
% of shares outstanding 10.4% Filing date Jul 8, 2024
BlackRock Inc. 5.4M 10.4% Jul 8, 2024
Rtw Investments, LP 5.9M
% of shares outstanding 9.9% Filing date May 15, 2026
Rtw Investments, LP 5.9M 9.9% May 15, 2026
Baker Bros. Advisors LP 4.4M
% of shares outstanding 8.3% Filing date Nov 14, 2024
Baker Bros. Advisors LP 4.4M 8.3% Nov 14, 2024
Lynx1 Capital Management LP 4.8M
% of shares outstanding 8.1% Filing date May 18, 2026
Lynx1 Capital Management LP 4.8M 8.1% May 18, 2026
FMR LLC 3.0M
% of shares outstanding 7.7% Filing date Feb 9, 2023
FMR LLC 3.0M 7.7% Feb 9, 2023
Morgan Stanley 3.4M
% of shares outstanding 7.5% Filing date Feb 9, 2024
Morgan Stanley 3.4M 7.5% Feb 9, 2024
Redmile Group, LLC 4.2M
% of shares outstanding 6.7% Filing date May 15, 2026
Redmile Group, LLC 4.2M 6.7% May 15, 2026
8 of 11

Stoke Therapeutics, Inc. (STOK) ownership FAQ

Who owns STOK?

194 reporting institutions disclosed STOK position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.